[1]
“Optimizing Norfloxacin Bioavailability: Formulation and Evaluation of Cyclodextrin-Based Tablets”, JIMP, vol. 1, no. 02, pp. 51–65, Aug. 2024, doi: 10.61920/jimp.v1i02.27.